StockData
EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Electromedical Technologies, Inc

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.00+0.00 (+9900.00%)

Close on Oct 19, 2026

Market cap
$68.10K
P/E (TTM)
–
Dividend yield
–

About Electromedical Technologies

Surgical & Medical Instruments & Apparatus, SIC 3841

Electromedical Technologies manufactures and markets bioelectronic medical devices designed for drug-free pain relief. Its flagship product is the WellnessPro Plus, an FDA-cleared transcutaneous electrical nerve stimulation device that delivers proprietary electrical frequencies to manage chronic and acute pain conditions. The business also develops additional bioelectric products, such as the WellnessPro POD wearable and the Wellness ION Pen cold-laser system. Its products serve individual consumers and healthcare practitioners, including chiropractors, physiotherapists, and specialists in pain management, natural medicine, and sports medicine.

The company operates primarily in the United States and maintains medical device certifications in the country. It employs six full-time personnel, four of whom work within the United States. Electromedical Technologies is headquartered in Scottsdale, Arizona, where it leases office and warehouse facilities.

Summary of the business section of Electromedical Technologies's latest annual report, written by StockData.

Company profile

Company

Legal name
Electromedical Technologies, Inc
Founded
2002
Headquarters
Scottsdale, AZ
Address
16561 N 92nd Street, Suite 101 85260
Phone
(888) 880-7888
Employees
6, Dec 31, 2023
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Dbbmckennon, San Diego, CA

Stock & identifiers

Ticker
EMED
Exchange
OTC
Shares outstanding
855M, Nov 19, 2024
Public float
$1.33M, Dec 31, 2023
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1715819
EIN
82-2619815

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Electromedical Technologies's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“As of December 31, 2023, we have 6 full-time employees, 4 of whom are U.S based, primarily at our Scottsdale, Arizona headquarters.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jul 14, 2025DeregistrationTermination of SEC registration (Form 15)
Mar 31, 2025Late filingNotification of late filing
Nov 14, 2024Late filingNotification of late filing
May 21, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
May 15, 2024Late filingNotification of late filing
Apr 3, 2024Late filingNotification of late filing
Nov 15, 2023Late filingNotification of late filing
Aug 14, 2023Late filingNotification of late filing
Mar 21, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 12, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)